HBK Investments’s Clorox CLX Stock Holding History

HBK Investments’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,800	Closed	-$3.31M	–	538
2022 Q1	$3.31M	Buy	+23,800	New	+$3.65M	0.01%	345
2021 Q2	–	Sell	-6,000	Closed	-$1.16M	–	839
2021 Q1	$1.16M	Buy	+6,000	New	+$1.15M	0.01%	574

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's CLX Position: Q2 2021 in Review

HBK Investments sold out of Clorox (CLX) in Q2 2021, closing a stake of 1,862 shares — an estimated $359K sold.

HBK Investments first reported a position in CLX in Q1 2015 and held it in 7 quarters. The position peaked at $857K in Q1 2019. 1,169 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

HBK Investments reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
HBK Investments sold 1,862 Clorox shares in Q2 2021, an estimated $359K.
HBK Investments first reported a position in Clorox in Q1 2015 and held it in 7 quarters.
HBK Investments's Clorox position peaked at $857K in Q1 2019.
1,169 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.